Theradiag SA - Asset Resilience Ratio

Latest as of June 2025: 15.59%

Theradiag SA (ALTHE) has an Asset Resilience Ratio of 15.59% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ALTHE capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€1.80 Million

≈ $2.10 Million USD Cash + Short-term Investments

Total Assets

€11.55 Million

≈ $13.50 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2023)

This chart shows how Theradiag SA's Asset Resilience Ratio has changed over time. See ALTHE equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Theradiag SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Theradiag SA market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.80 Million	15.59%
Total Liquid Assets	€1.80 Million	15.59%

Asset Resilience Insights

Good Liquidity Position: Theradiag SA maintains a healthy 15.59% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Theradiag SA Industry Peers by Asset Resilience Ratio

Compare Theradiag SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Inspire Medical Systems Inc NYSE:INSP	Medical Devices	20.29%
Shanghai General Healthy Information and Technology Co. Ltd. SHG:605186	Medical Devices	0.84%
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	Medical Devices	19.31%
Stratec SE XETRA:SBS	Medical Devices	0.30%
Duearity AB ST:DEAR	Medical Devices	145.62%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for Theradiag SA (2010–2023)

The table below shows the annual Asset Resilience Ratio data for Theradiag SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.12%	€-21.82K ≈ $-25.51K	€18.66 Million ≈ $21.82 Million	-0.34pp
2022-12-31	0.22%	€31.10K ≈ $36.36K	€13.94 Million ≈ $16.30 Million	-0.04pp
2021-12-31	0.26%	€31.10K ≈ $36.36K	€11.83 Million ≈ $13.83 Million	-0.03pp
2020-12-31	0.29%	€31.10K ≈ $36.36K	€10.55 Million ≈ $12.33 Million	0.00pp
2019-12-31	0.30%	€31.10K ≈ $36.36K	€10.51 Million ≈ $12.29 Million	-0.03pp
2018-12-31	0.33%	€31.10K ≈ $36.36K	€9.56 Million ≈ $11.18 Million	+0.10pp
2017-12-31	0.23%	€31.10K ≈ $36.36K	€13.77 Million ≈ $16.10 Million	-33.97pp
2016-12-31	34.19%	€5.03 Million ≈ $5.88 Million	€14.71 Million ≈ $17.20 Million	+14.41pp
2015-12-31	19.78%	€1.83 Million ≈ $2.14 Million	€9.26 Million ≈ $10.82 Million	+1.29pp
2014-12-31	18.50%	€1.53 Million ≈ $1.79 Million	€8.28 Million ≈ $9.69 Million	+17.44pp
2013-12-31	1.06%	€31.10K ≈ $36.36K	€2.94 Million ≈ $3.44 Million	+0.08pp
2012-12-31	0.97%	€31.10K ≈ $36.36K	€3.20 Million ≈ $3.74 Million	-23.96pp
2011-12-31	24.93%	€575.16K ≈ $672.42K	€2.31 Million ≈ $2.70 Million	+24.66pp
2010-12-31	0.27%	€10.60K ≈ $12.39K	€3.91 Million ≈ $4.57 Million	--

pp = percentage points

About Theradiag SA

PA:ALTHE France Medical Devices

Market Cap

$48.35 Million

€41.36 Million EUR

Market Cap Rank

#23058 Global

#365 in France

Share Price

€0.70

Change (1 day)

-6.67%

52-Week Range

€0.31 - €0.87

All Time High

€8.20